See related research by Spahn *et al*., <http://ccforum.com/content/17/2/R76>

In the latest recommendations for the management of bleeding following major trauma, Spahn and colleagues recommend a target haemoglobin of 7 to 9 g/dl to initiate blood transfusion \[[@B1]\]. In their rationale the authors use a subgroup of trauma patients from the Transfusion Requirements in Critical Care study; however, patients with active blood loss were excluded from this trial.

Expressing a current opinion about transfusion and trauma patients, in 2006 McIntyre and Hebert wrote: \'It is important to put RBC \[red blood cell\] transfusions into the context of three main time frames, i.e. prehospital care, initial 24-48 h after admission to hospital and thereafter, because each frame has its own set of circumstances which may dictate the need for different timing, volume and rapidity of transfusions\' \[[@B2]\]. To our knowledge, the only trial to evaluate a target haemoglobin in shock involved early goal-directed therapy in septic shock \[[@B3]\]. The early goal-directed therapy protocol included maintaining a haematocrit of 30% (haemoglobin at 10 g/dl). In the results, the early goal-directed therapy group had a significantly higher haematocrit than the control group and also received more transfusions.

Raising the target haemoglobin to 10 g/dl has two interesting effects: haemodilution is reduced, harmful in the present case; and the transfusion delay is decreased. Riskin and colleagues showed that reducing the transfusion delay may decrease the mortality rate \[[@B4]\]. For the first time, three studies suggest that transfusion may be associated with a reduced mortality rate \[[@B5]\].

The real beneficial effect of blood transfusion is probably that it gives time to stop the bleeding.
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